UC Davis Health Ventures

UC Davis Health Ventures is the corporate venture capital arm of UC Davis Health, dedicated to translating innovative research into market-ready solutions that enhance human health. Operating within the university's Innovation and Economic Development Office, it fosters collaborations among researchers, clinicians, investors, and industry partners to accelerate the commercialization of groundbreaking healthcare technologies. The venture arm is headquartered at Aggie Square, UC Davis's innovation district in Sacramento, California.

The investment strategy of UC Davis Health Ventures encompasses a broad spectrum of healthcare and life sciences sectors, including biotechnology, medical devices, digital health, pharmaceuticals, diagnostics, regenerative medicine, oncology, neuroscience, cardiology, orthopedics, immunology, infectious diseases, and public health. The firm focuses on various stages of company development, from seed and early-stage investments to growth, late-stage, and pre-IPO funding. Investment sizes range from $1 million to $50 million, aligning with the firm's commitment to supporting companies at different stages of their growth trajectory.

UC Davis Health Ventures has been instrumental in launching initiatives such as the Health Venture Studio and the Investing in the Future of Medicine (IFM) Fund. These programs aim to expedite the translation of university research into real-world health solutions. The Health Venture Studio identifies and advances promising UC Davis interdisciplinary research innovations in therapeutics, digital health, molecular diagnostics, and medical devices. The IFM Fund, a $25 million investment initiative, complements the studio by directly funding cutting-edge research and the incubation of startups emerging from UC Davis, as well as investing in high-potential companies from outside the university that align with its mission. Through these efforts, UC Davis Health Ventures continues to drive innovation and economic growth in the healthcare sector, reinforcing its role as a catalyst for transformative health solutions.